Abstract
Depression in adult patients with cancer may lead to decreased treatment adherence, decreased quality of life, and possible suicidal ideation. Adequate screening can promote timely diagnosis and treatment of depression. A quality improvement project was implemented at a cancer center in which adult patients are diagnosed with and treated for cancer. A paper version of the 9-item Patient Health Questionnaire (PHQ-9), a validated tool to screen for depression, was provided to patients during their scheduled appointment. A two-sample test of proportions was used to compare the proportion of patients screened before project implementation to the proportion of patients screened after project implementation. Depression screening rates increased from 2% before to 12% after project implementation. Frequent screening with the PHQ-9 should occur in adult patients with cancer to adequately identify depressive symptoms. Adequate screening will provide the necessary information for providers to make referrals to mental health services and allow patients to adhere to their treatment plans, improving their quality of life.
References
Arrieta, J., Aguerrebere, M., Raviola, G., Flores, H., Elliott, P., Espinosa, A.,…Franke, M. F. (2017). Validity and utility of the Patient Health Questionnaire (PHQ)-2 and PHQ-9 for screening and diagnosis of depression in Rural Chiapas, Mexico: A cross-sectional study. Journal of Clinical Psychology, 73(9), 1076–1090. https://doi.org/10.1002/jclp.22390
Bortolato, B., Hyphantis, T. N., Valpione, S., Perini, G., Maes, M., Morris, G.,…Carvalho, A. F. (2017). Depression in cancer: The many biobehavioral pathways driving tumor progression. Cancer Treatment Reviews, 52, 58–70. https://doi.org/10.1016/j.ctrv.2016.11.004
Dadfar, M., Lester, D., Hosseini, A. F., & Eslami, M. (2021). The Patient Health Questionnaire-9 (PHQ-9) as a brief screening tool for depression: A study of Iranian college students. Mental Health, Religion & Culture, 24(8), 850–861. https://doi.org/10.1080/13674676.2021.1956884
Dajpratham, P., Pukrittayakamee, P., Atsariyasing, W., Wannarit, K., Boonhong, J., & Pongpirul, K. (2020). The validity and reliability of the PHQ-9 in screening for post-stroke depression. BioMed Central Psychiatry, 20(1), 291. https://doi.org/10.1186/s12888-020-02699-6
Decker, V.B. & Tofthagen, C. (2021). Depression: Screening, assessment, and interventions in oncology nursing. Clinical Journal of Oncology Nursing, 25(4), 413–421. https://doi.org/10.1188/21.CJON.413-421
Degefa, M., Dubale, B., Bayouh, F., Ayele, B., & Zewde, Y. (2020). Validation of the PHQ-9 depression scale in Ethiopian cancer patients attending the oncology clinic at Tikur Anbessa specialized hospital. BioMed Central Psychiatry, 20(1), 446. https://doi.org/10.1186/s12888-020-02850-3
Ganz, P. A., Bower, J. E., Partridge, A. H., Wolff, A. C., Thorner, E. D., Joffe, H.,…Crespi, C. M. (2021). Screening for
depression in younger breast cancer survivors: Outcomes from use of the 9-item Patient Health Questionnaire. JNCI Cancer Spectrum, 5(3), pkab017. https://doi.org/10.1093/jncics/pkab017
Gorman, D. C., Ham, S. A., Staab, E. M., Vinci, L. M., & Laiteerapong, N. (2021). Medical assistant protocol improves disparities in depression screening rates. American Journal of Preventive Medicine, 61(5), 692–700. https://doi.org/10.1016/j.amepre.2021.05.010
Hahn, E. E., Munoz-Plaza, C. E., Pounds, D., Lyons, L. J., Lee, J. S., Shen, E.,…Gould, M. K. (2022). Effect of a community-based medical oncology depression screening program on behavioral health referrals among patients with breast cancer: A randomized clinical trial. Journal of the American Medical Association, 327(1), 41–49. https://doi.org/10.1001/jama.2021.22596
Kroenke, K., Spritzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2003). The Patient Health Questionnaire-2: validity of a two-item depression screener. Medical Care, 41(11), 1284–1292. https://doi.org/10.1097/01.MLR.0000093487.78664.3C
Levis, B., Benedetti, A., Thombs, B. D., & DEPRESsion Screening Data (DEPRESSD) Collaboration (2019). Accuracy of patient health questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. British Medical Journal, 365, 1,476. https://doi.org/10.1136/bmj.l1476
Levis, B., Sun, Y., He, C., Wu, Y., Krishnan, A., Bhandari, P. M.,…Zhang, Y. (2020). Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression: Systematic review and meta-analysis. Journal of the American Medical Association, 323(22), 2290–2300. https://doi.org/10.1001/jama.2020.6504
Lysandrou, M., Quaye, N., Landes, K., Crawford, R. D., Desai, P., Creary, S.,…Cronin, R. M. (2024). Evaluating self- vs interviewer-administered screening for depression in sickle cell disease. Blood Advances, 8(3), 699–702. https://doi.org/10.1182/bloodadvances.2023012083
Mansour, M., Krishnaprasadh, D., Lichtenberger, J., & Teitelbaum, J. (2020). Implementing the patient health questionnaire modified for adolescents to improve screening for depression among adolescents in a federally qualified health centre. British Medical Journal Open Quality, 9(4), e000751. https://doi.org/10.1136/bmjoq-2019-000751
Mitchell A. J. (2013). Screening for cancer-related distress: When is implementation successful and when is it unsuccessful? Acta Oncologica, 52(2), 216–224. https://doi.org/10.3109/0284186X.2012.745949
Mulvihill, E., Furru, R., Goldstein-Leever, A., Driest, K., Lemle, S., MacDonald, D.,…Sivaraman, V. (2021). Targeted provider education and pre-visit planning increase rates of formal depression screening in childhood-onset SLE. Pediatric Rheumatology Online Journal, 19(1), 116. https://doi.org/10.1186/s12969-021-00576-4
National Cancer Institute. (2021). Common terminology criteria for adverse events (CTCAE). U.S. Department of Health and Human Services, National Institutes of Health. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50
Negeri, Z. F., Levis, B., Sun, Y., He, C., Krishnan, A., Wu, Y.,…Depression Screening Data (DEPRESSD) PHQ Group (2021). Accuracy of the patient health questionnaire-9 for screening to detect major depression: Updated systematic review and individuals participant data meta-analysis. British Medical Journal, 375, n2183. https://doi.org/10.1136/bmj.n2183
Pilevarzadeh, M., Amirshahi, M., Afsargharehbagh, R., Rafiemanesh, H., Hashemi, S. M., & Balouchi, A. (2019). Global prevalence of depression among breast cancer patients: A systematic review and meta-analysis. Breast Cancer Research and Treatment, 176(3), 519–533. https://doi.org/10.1007/s10549-019-05271-3
Rancans, E., Trapencieris, M., Ivanovs, R., & Vrublevska, J. (2018). Validity of the PHQ-9 and PHQ-2 to screen for depression in nationwide primary care population in Latvia. Annals of General Psychiatry, 17, 33. https://dx.doi.org/10.1186/s12991-018-0203-5
UpToDate. (2022). Common terminology criteria for adverse events. https://www.uptodate.com/contents/common-terminology-criteria-for-adverse-events#H1157547
